Pagoclone -: Anxiolytic GABA-A/BZD site partial agonist

被引:49
|
作者
Sorbera, LA [1 ]
Leeson, PA [1 ]
Silvestre, J [1 ]
Castañer, J [1 ]
机构
[1] Prous Sci, Barcelona 08040, Spain
关键词
as monohydrochloride;
D O I
10.1358/dof.2001.026.07.630003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Pagoclone has been obtained by several related ways: 1) Condensation of 7-hydroxy-1,8-naphthyridin-2-amine (1) with phthalic anhydride (II) in refluxing acetic acid gives N-(7-hydroxy-1,8-naphthyridin-2-yl)phthalimide (III), which is treated with refluxing POCl3 to yield the 7-chloro derivative (IV). Reduction of compound (IV) with KBH4, in dioxane affords 2-(7-chloro-1,8-naphthyridin-2-yi)-3-hydroxyisoindolin-1 -one (V) (1, 2), which is condensed with 5-methyl-2-hexanone (VI) by means of NaH in DMF to give (+/-)-2-(7-chloro-1,8-naphthyridin-2-yi)-3-(5-methyl-2-oxohexyl)isoindolin-1 -one (VII) (racemic pagoclone) (3).The treatment of (VII) with NaOH in dioxane/ water yields the racemic benzoic acid (VI H) (4-6). Optical resolution of racemic (VIII) by means of (+)-ephedrine (4, 5) or cinchonine (6, 7) affords the (+)-isomer (IX), which is finally cyclized to the chiral (+)-indolinone derivative pagoclone by means of SOCl2 and imidazole in dichloromethane (4-7). Scheme 1. 2) The isoindolinone (VII) (racemic pagoclone) can also be obtained by reaction of isoindolinone (V) with SOCl2 in DMF to provide 3-chloro-2-(7-chloro-1,8-naphthyridin-2-yl)isoindolin-1 -one (X), which is condensed with 3-oxo-6-methylheptanoic acid ethyl ester (XI) by means of NaH in DMF to yield 2-[2-(7-chloro-1,8-naphthyridin-2-yl)-3-oxoisoindolin-1-yl]-6-methyl-3-oxoheptanoic acid ethyl ester (XII). Finally, this compound is decarboxylated to the indolinone (VII) by means of LiCl in refluxing DMSO/water (3) Scheme 2. 3) The racemic benzoic acid (VIII) can also be obtained by hydrolysis of the heptanoic ester (XII) with concentrated sulfuric acid to give the corresponding free acid (XIII), which is finally decarboxylated and hydrolyzed by means of NaOH in water (6, 7). Scheme 2. 4) The optical resolution of racemic pagoclone (VII) can also be performed by reaction with (-)-(1R,2R,3S,5R)-pinanediol (XIV) by means of PPTS in refluxing dichloroethane to give the ketal (XV) as a diastereomeric mixture separated by crystallization. Finally, hydrolysis of the desired diastereomer (XVI) with 12N HCl affords the (+)-enantiomer, pagoclone (8). Scheme 3.
引用
收藏
页码:651 / 657
页数:7
相关论文
共 50 条
  • [1] Evaluation of the abuse potential of pagoclone, a partial GABAA agonist
    de Wit, Harriet
    Vicini, Lisa
    Haig, George M.
    Hunt, Thomas
    Feltner, Douglas
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2006, 26 (03) : 268 - 273
  • [2] Indiplon.: Treatment of insomnia, GABA-A agonist
    Sorbera, LA
    Castañer, J
    Martín, L
    DRUGS OF THE FUTURE, 2003, 28 (08) : 739 - 746
  • [3] Propofol increases agonist efficacy at the GABA-A receptor
    Harrison, NL
    Wong, LC
    O'Shea, SM
    ANESTHESIOLOGY, 1999, 91 (3A) : U359 - U359
  • [4] CHRONIC EXPOSURE TO A BENZODIAZEPINE PARTIAL AGONIST DOES NOT ALTER GABA-A RECEPTOR FUNCTION IN CULTURED NEURONS
    MILLER, LG
    HELLER, J
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 199 (01) : 111 - 113
  • [5] Effects of the GABA-A receptor agonist THIP on the sleep EEG of GABA-A receptor delta subunit knockout mice
    Winsky-Sommerer, R.
    Vesely, M.
    Tobler, I.
    SLEEP, 2006, 29 : A21 - A21
  • [6] Evidence for mechanism of action of the GABA-A receptor agonist THIP in GABA-A receptor delta subunit knockout mice
    Winsky-Sommerer, R.
    Tobler, I.
    JOURNAL OF SLEEP RESEARCH, 2006, 15 : 238 - 238
  • [7] GABA-A selective positive modulators: Anxiolytic efficacy versus side effects
    West, E
    Lautenslager, T
    Smolka, J
    Hudzik, T
    Maciag, C
    FASEB JOURNAL, 2006, 20 (04): : A235 - A235
  • [8] Relationship between dose, plasma concentration and GABA-A receptor occupancy by partial GABA-A receptor modulators
    Jucaite, A.
    Lappalainen, J.
    Cselenyi, Z.
    Varnas, K.
    Stenkrona, P.
    Halldin, C.
    Cross, A.
    Farde, L.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S274 - S274
  • [9] Identifying the GABA-A receptor ivermectin binding site
    Estrada, A.
    Lynch, J. W.
    JOURNAL OF NEUROCHEMISTRY, 2015, 134 : 156 - 157
  • [10] PET EVALUATION OF GABA SENSITIVITY OF BENZODIAZEPINE (BZD) SITE AGONIST [11C]RO6899880 IN THE MONKEY BRAIN
    Finnema, S. J.
    Stepanov, V.
    Amini, N.
    Martinsson, S.
    Borroni, E.
    Honer, M.
    Gobbi, L.
    Grimwood, S.
    Farde, L.
    Halldin, C.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2016, 36 : 662 - 662